Back to
FEDERATED HERMES, INC.
KALV11 quarters
Position history for
FEDERATED HERMES, INC.'s holdings in KALVISTA PHARMACEUTICALS INC
As of its Q1 2026 13F, Federated Hermes held 3,719 shares of KALV (Kalvista Pharmaceuticals), worth $74,864. Federated Hermes' 13F filings listed KALV from Q4 2025 to Q1 2026, 2 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$6,000
Total Shares Change
-286
Quarter-by-Quarter History
Other major holders of KALV: BlackRock, Inc., Capital World Investors, MILLENNIUM MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P.